Switzerland-Brazil Call 2022 focusing on Research and Development

Deadline: 15-Jun-22

Participants from Switzerland and Brazil are invited to submit joint project proposals for research and development of innovative products and applications with a strong market potential in Switzerland and Brazil.

The innovation promotion agency of Brazil (Empresa Brasileira de Pesquisa e Inovação Industrial – EMBRAPII) with the support of Apex-Brasil and the Swiss Innovation Agency – Innosuisse announce the 3rd edition of the TechMakers Brazil-Switzerland joint call to fund science-based innovation projects between Switzerland and Brazil.

The joint call 2022 focuses on research and development ranging from experimental proof of concept to technology demonstrated in relevant environment, leading to innovative solutions, which are considerably differentiated from comparable existing solutions in the market in terms of their functions, parameters or other features.

They shall provide added economic, societal or environmental values, which have a significant market potential in Brazil and Switzerland.

Topics

The call is open for all scientific disciplines; however, projects in the following topics are particularly appreciated:

• Biotech; Medtech
• Agriculture and food production
• Digitalisation; Industry 4.0
• Advanced materials
• Information and communication technologies
• Cleantech; Clean energy & water
• Sustainable cities and communities
• Innovation and creativity (social, technical, cultural)
• Mobility

Eligibility Criteria

All proposals must meet following eligibility criteria to be qualified for evaluation:

• The project consortia must include at least one business entity from each country, one research institute accredited by EMBRAPII as “EMBRAPII unit” and one research institute from Switzerland.
• The participation of further research organizations and further commercial companies from both countries according to each country’s funding regulations is welcome.
• The eligibility for funding of research organizations and commercial companies must comply with the regulations of their respective country.
• The project partners shall name one designated main project contact. EMBRAPII Units and Swiss research institutes will be automatically considered as national contacts.
• The project should demonstrate a relevant innovation content, added-value and benefit from the bilateral cooperation in both countries. The project must be equally significant to all participants. One country cannot represent more than 70% of the overall project person-months.
• With the proposal, the consortium is encouraged to present a draft agreement on the Intellectual Property Rights (IPR) together with the proposal, in order to reduce the negotiation time after the proposal approval and project start.
• Both agencies will only consider project costs, which arise in their country eligible for funding. Cross-border funding is not foreseen.

For more information, visit https://www.innosuisse.ch/inno/en/home/go-global/tenders-overview.html#-1042449694